Long-term albumin administration has shown promise in reducing complications of cirrhosis, including infections and renal dysfunction, while short-term use is standard in specific contexts such as large-volume paracentesis, spontaneous bacterial peritonitis, and HRS [5]. Here, ALB is linked to Cirrhosis.